Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary M Horowitz

Showing results (131-140 of 260) with videos related to

Pageof 26
Sort By:
Blood|July 2, 2014
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCTCorey Cutler, Brent Logan, Ryotaro Nakamura, et al.
Blood|April 19, 2013
Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantationMarcelo A Fernández-Viña, John P Klein, Michael Haagenson, et al.
The Lancet. Oncology|October 11, 2011
Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysisMary Eapen, John P Klein, Guillermo F Sanz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2016
Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety StudyGalen E Switzer, Jessica Bruce, Deidre M Kiefer, et al.
Open Forum Infectious Diseases|October 11, 2021
Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?John R Wingard, Barbara D Alexander, Lindsey R Baden, et al.
Cancer|August 10, 2021
Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementationErica D Warlick, Celalettin Ustun, Astrid Andreescu, et al.
Blood|October 29, 2005
131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remissionJohn M Pagel, Frederick R Appelbaum, Janet F Eary, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocolGregory A Yanik, Mary M Horowitz, Daniel J Weisdorf, et al.
Blood|July 2, 2002
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapseStephanie J Lee, John P Klein, A John Barrett, et al.
Haematologica|January 21, 2018
Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-<i>versus</i>-host disease: low incidence of lower gastrointestinal tract diseaseWilliam R Drobyski, Aniko Szabo, Fenlu Zhu, et al.
Pageof 26

Showing results (131-140 of 260) with videos related to

Sort By:
Pageof 26
Blood|July 2, 2014
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCTCorey Cutler, Brent Logan, Ryotaro Nakamura, et al.
Blood|April 19, 2013
Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantationMarcelo A Fernández-Viña, John P Klein, Michael Haagenson, et al.
The Lancet. Oncology|October 11, 2011
Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysisMary Eapen, John P Klein, Guillermo F Sanz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2016
Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety StudyGalen E Switzer, Jessica Bruce, Deidre M Kiefer, et al.
Open Forum Infectious Diseases|October 11, 2021
Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?John R Wingard, Barbara D Alexander, Lindsey R Baden, et al.
Cancer|August 10, 2021
Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementationErica D Warlick, Celalettin Ustun, Astrid Andreescu, et al.
Blood|October 29, 2005
131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remissionJohn M Pagel, Frederick R Appelbaum, Janet F Eary, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocolGregory A Yanik, Mary M Horowitz, Daniel J Weisdorf, et al.
Blood|July 2, 2002
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapseStephanie J Lee, John P Klein, A John Barrett, et al.
Haematologica|January 21, 2018
Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-<i>versus</i>-host disease: low incidence of lower gastrointestinal tract diseaseWilliam R Drobyski, Aniko Szabo, Fenlu Zhu, et al.
Pageof 26